Comptroller-General of Customs v Pharm-A-Care Laboratories Pty Ltd

The Comptroller-General of Customs (the Comptroller) appealed to the Full Federal Court against a decision of the Federal Court of Australia concerning the classification of certain pharmaceutical products imported by Pharm-A-Care Laboratories Pty Ltd (Pharm-A-Care). The dispute centred on whether these products, described as "oral rehydration salts" and "oral rehydration solutions," were correctly classified under Item 3004.90.00 of Schedule 1 to the Customs Tariff Act 1995 (Cth) (the Tariff Act) as "medicaments" or under Item 2106.90.00 as "food preparations not elsewhere specified or included." The primary judge had found in favour of Pharm-A-Care, holding that the products were not medicaments.

The Full Federal Court was required to determine whether the products in question, which were presented as powders to be mixed with water for oral consumption to treat dehydration, qualified as "medicaments" for the purposes of the Tariff Act. This involved an interpretation of the term "medicament" within the context of the Tariff Act and its Explanatory Notes, and whether the products' primary purpose and function aligned with the definition of a medicament, particularly in contrast to a food preparation.

Gageler and Keane JJ, in allowing the Comptroller's appeal, reasoned that the Explanatory Notes to Chapter 30 of the Harmonised System Nomenclature, which informed the interpretation of the Tariff Act, provided a broad definition of "medicaments" that encompassed preparations for the treatment or prevention of disease. Their Honours found that the oral rehydration salts and solutions, by virtue of their composition and intended use in restoring electrolyte and fluid balance in cases of dehydration, served a therapeutic purpose and were therefore correctly classified as medicaments under Item 3004.90.00. The court held that the primary judge had erred in focusing too narrowly on whether the products were "drugs" in a pharmaceutical sense, rather than on their broader therapeutic function as medicinal preparations. The appeal was allowed, and the matter remitted to the primary judge for further consideration.